Shots: The P-II/III EPIC-HR evaluates Paxlovid vs PBO in non-hospitalized adult patients with COVID-19 who are at high risk of progressing to severe illness In an interim analysis, the therapy […]readmore
Tags : P-II/III
Shots: The P-II/III KidCOVE study evaluated the safety, tolerability, reactogenicity & effectivity of mRNA-1273 in 4753 children aged 6-12yrs. with COVID-19, administered as 28 days apart The study met its […]readmore
Shots: The P-II/III study evaluates opaganib +SoC vs PBO + SoC in a ratio (1:1) in 475 patients with COVID-19 pneumonia requiring hospitalization & treatment with supplemental oxygen The preliminary […]readmore
Clinical Trials
COVID-19
AstraZeneca Reports First Patient Vaccinating in P-II/III D7220C00001 Trial for
Shots: The 1st patient has been vaccinated in a P- II/III D7220C00001 trial assessing the safety & immunogenicity of AZD2816 in 2,250 adults aged >18yrs. with COVID-19 in both previously […]readmore
Shots: The P-II/III ORIENT-32 study evaluates the efficacy & safety of sintilimab (200mg, q3w) + IBI305 (15 mg/kg, q3w) vs sorafenib (400 mg, PO, bid) as 1L treatment in patients […]readmore
Shots: The company has stopped the P-II/III STAGED-PKD study for not meeting futility criteria that assess venglustat vs PBO in patients with ADPKD, following an independent analysis of the annualized […]readmore
Shots: The P-II/III TeenCOVE study involves assessing mRNA-1273 (two 100 µg doses) vs PBO in 3700+ participants in a ratio (2:1) aged 12 to <18yrs. in the US The study […]readmore
Shots: The first patient has been dosed in a P-II/III clinical trial of HLX10 in combination with HLX04 (bevacizumab) and CT for 1L treatment of mCRC The combination regimen aims […]readmore
Shots: Clover plans to initiate a global P-II/III efficacy trial with the S-Trimer COVID-19 vaccine candidate adjuvanted with CpG 1018 plus alum in the H1’2021 with an interim analysis for […]readmore
Shots: Interim analysis results of COV002 & COV003 study of AZD1222 in the UK & Brazil showed the vaccine is effective in preventing COVID-19 and no hospitalizations/ severe cases of […]readmore